Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trial (Q40182275)
Jump to navigation
Jump to search
scientific article published on 18 November 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trial |
scientific article published on 18 November 2014 |
Statements
1 reference
Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trial (English)
1 reference
M T Ashworth
S Swann
K Flaherty
J Weber
J R Infante
K B Kim
R Gonzalez
O Hamid
L Schuchter
J A Sosman
S Little
P Sun
G Aktan
D Ouellet
18 November 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference